Title : Metformin Treatment for Patients with Diabetes and Chronic Kidney Disease: A Korean Diabetes Association and Korean Society of Nephrology Consensus Statement.

Pub. Date : 2020 Feb

PMID : 32097995






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Metformin can be used safely when the estimated glomerular filtration rate (eGFR) is >=45 mL/min/1.73 m2. Metformin CD59 molecule (CD59 blood group) Homo sapiens
2 If the eGFR is between 30 and 44 mL/min/1.73 m2, metformin treatment should not be started. Metformin CD59 molecule (CD59 blood group) Homo sapiens
3 Metformin is contraindicated when the eGFR is <30 mL/min/1.73 m2. Metformin CD59 molecule (CD59 blood group) Homo sapiens
4 During procedures involving intravenous administration of ICM, metformin should be discontinued starting the day of the procedures and up to 48 hours post-procedures if the eGFR is <60 mL/min/1.73 m2. Metformin CD59 molecule (CD59 blood group) Homo sapiens